Month: September 2024

A great year of Malaria research has been overshadowed by the global pandemic of COVID-19. Headlines on promising new vaccines and prevention strategies barely survive the 24-hour news cycle, quickly superseded by the latest COVID-19 related research. Malaria remains a leading cause of death in children under the age of…

New Year, Same Pandemic The turn of the year has come and gone but a lot of the news feels the same in year two of the COVID19 pandemic. Many countries are experiencing severe 2nd and 3rd waves of infection. Highly transmissible new variants of the virus cast a cloud on the…

A new long-acting option for HIV PrEP On Thursday, June 20, 2024, Gilead released the highly anticipated topline results of the PURPOSE-1 trial. This phase three randomized controlled trial demonstrated that a twice-yearly subcutaneous injection of the antiretroviral drug Lenacapavir was 100% effective in preventing HIV infection. This is in compared…

Cameroon’s Ministry of Public Health has announced it will further investigate an outbreak of yaws, which over the past few months, has affected hundreds of Baka and Bantu people in the Lomie Health District in the east of the country. Neighbouring districts are also reported to be affected. “We dispatched…

On 14-18 November 2022, representatives and staff members from the World Health Organization, UNICEF, GAVI, USAID and Africa Centres for Disease Control (CDC) came together during a high level COVID-19 vaccine delivery partnership (CoVDP) mission in Yaoundé, Cameroon to discuss plans to accelerate COVID-19 vaccinations in the country.  Although Cameroon…